Portfolio Companies News
August 15, 2018Targovax ASA: Invitation to second ...
Oslo, Norway, 15 August 2018 - Targovax ASA (OSE: TRVX), a clinical stage biotechnology company developing immune activators to target hard to treat solid tumors, will announce its second quarter and first half year 2018 results on Thursday, 23 August 2018. A presentation by Targovax's management to... read more
August 14, 2018Strongbridge Biopharma plc Announce...
DUBLIN, Ireland and TREVOSE, Pa., Aug. 14, 2018 (GLOBE NEWSWIRE) -- Strongbridge Biopharma plc (NASDAQ:SBBP) (the “Company”) today announced that it intends to offer and sell 9,000,000 of its ordinary shares in an underwritten public offering. The Company also intends to grant the underwri... read more
August 10, 2018MIPS: Invitation to the presentatio...
Fri, Aug 10, 2018 14:00 CETMIPS releases its Interim report for the period January to June on August 16 at 7:30 am (CET). Johan Thiel, President and CEO and Max Strandwitz CFO, will present the results the same day at 10:00 am CET, at a conference call. The conference call will be held in... read more
August 9, 2018Notice of Nexstim Plc's Half-Yearly...
Company announcement, Helsinki, 9 August 2018 at 9:00 AM Nexstim Plc (NXTMH:HEX, NXTMS:STO) ("Nexstim" or the "Company"), the targeted neuromodulation company developing and marketing pioneering navigated non-invasive brain stimulation systems for both therapeutic and diagnostic application, will... read more
August 9, 2018Anders Martin-Löf has been appoint...
Stockholm – August 9, 2018 – Oncopeptides AB (Nasdaq Stockholm: ONCO) announced today that Anders Martin-Löf, has been appointed as the new CFO of Oncopeptides and will join the company in November. CFO Birgitta Ståhl has decided to step down as the CFO as the Company expands the orga... read more
July 24, 2018Q2 2018 General Market Overview
Since the start in 1996, HealthCap funds have invested in 112 portfolio companies.
41 of the portfolio companies have been taken public on nine different markets.
25 of the portfolio companies’ pharmaceutical products have been approved for marketing.
Since the start in 1996, HealthCap has helped build 7 companies with a valuation of USD 1 billion or more and 35 companies with a valuation of SEK 1 billion or more.